… In summary, the new high dosage influenza vaccine evaluated in this study was well … serum
antibody responses than licensed standard dosage vaccine. Available information indicates …

… in patients with rheumatoid arthritis versus healthy controls. Reported proportions of patients
with … A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus …

… dose strategies for improving influenza vaccine immunogenicity in the elderly with an ID device
and an adjuvanted vaccine… improved immunogenicity to standard presentation in at least …

… In this multicentre, randomised, controlled, phase 4 trial, adults in receipt of a single dose of
… appropriate influenza vaccine or placebo alongside their second dose of COVID-19 vaccine. …

… A previously constructed inactivated vaccine with adjuvant revealed an association … phase
II trial, we aimed to evaluate the safety and immunogenicity of an intranasal influenza vaccine …

… to enhanced influenza vaccines, compared to standard-dose vaccines, in … burden of influenza
epidemics [1]. The most widely used influenza vaccines are inactivated influenza vaccines, …

… High-dose inactivated influenza vaccine (HD-IIV), with increased antigen content compared
to standard-dose influenza vaccines … We controlled for these differences by adjusting for age, …

… gap, we performed a phase III placebo-controlled clinical trial in … vaccine used in this study
contained a full dose of antigen (15 µg hemagglutinin [HA] per strain) rather than a half dose …

… This trivalent high-dose vaccine is the only influenza vaccine licensed for use in adults 65 …
a standard dose influenza vaccine for the prevention of laboratory-confirmed influenza illness […

… was compared with a control vaccine (Fluvirin ® , Novartis Vaccines and Diagnostics). A …
receive one vaccination of one of the three lots of influenza vaccine or control vaccine. Antibody …